Role of Melanin and a Novel Na:Ca:K Exchanger in AMD
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
April 01, 2006 - September 28, 2010
Grant ID
M2006068
Summary
Age-related macular degeneration (AMD) is the leading cause of impaired vision among the elderly in the U.S. Progression of this condition to irreversible blindness is more likely to occur in Caucasians than in Blacks. This finding has led to the suggestion that having more eye pigmentation (melanin) protects against aging changes that cause vision loss in advanced AMD. We propose that a newly discovered protein, called NCKX5, is necessary for pigment synthesis and that impaired functioning of this protein will predispose to the development of advanced AMD. This project will examine the possible role of this novel calcium transport protein in the development of AMD. The activity of NCKX5 in eye cells from Black versus Caucasian donor eyes will be examined. In addition, the project will determine if an experimental animal, the zebrafish mutant golden, which lacks pigment due to mutation of NCKX5, exhibits eye changes like those seen in human AMD. This study will open up new avenues of research into the causes of AMD and will establish whether a powerful animal model, the zebrafish mutant golden, can be used to rapidly and inexpensively test new drugs and clinical protocols to treat AMD.
Grants
Related Grants
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Krishna Singh, PhD
Macular Degeneration Research
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shintaro Shirahama, MD, PhD